Universität zu Köln

Rabe, E., Breu, F. X., Cavezzi, A., Smith, P. Coleridge, Frullini, A., Gillet, J. L., Guex, J. J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, A. A., Tessari, L. and Pannier, F. (2014). European guidelines for sclerotherapy in chronic venous disorders. Phlebology, 29 (6). S. 338 - 355. THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 1758-1125

Full text not available from this repository.

Abstract

Aim: Sclerotherapy is the targeted chemical ablation of varicose veins by intravenous injection of a liquid or foamed sclerosing drug. The treated veins may be intradermal, subcutaneous, and/or transfascial as well as superficial and deep in venous malformations. The aim of this guideline is to give evidence-based recommendations for liquid and foam sclerotherapy. Methods: This guideline was drafted on behalf of 23 European Phlebological Societies during a Guideline Conference on 7-10 May 2012 in Mainz. The conference was organized by the German Society of Phlebology. These guidelines review the present state of knowledge as reflected in published medical literature. The regulatory situation of sclerosant drugs differs from country to country but this has not been considered in this document. The recommendations of this guideline are graded according to the American College of Chest Physicians Task Force recommendations on Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines. Results: This guideline focuses on the two sclerosing drugs which are licensed in the majority of the European countries, polidocanol and sodium tetradecyl sulphate. Other sclerosants are not discussed in detail. The guideline gives recommendations concerning indications, contraindications, side-effects, concentrations, volumes, technique and efficacy of liquid and foam sclerotherapy of varicose veins and venous malformations.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Rabe, E. UNSPECIFIED UNSPECIFIED UNSPECIFIED Breu, F. X. UNSPECIFIED UNSPECIFIED UNSPECIFIED Cavezzi, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Smith, P. Coleridge UNSPECIFIED UNSPECIFIED UNSPECIFIED Frullini, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Gillet, J. L. UNSPECIFIED UNSPECIFIED UNSPECIFIED Guex, J. J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Hamel-Desnos, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Kern, P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Partsch, B. UNSPECIFIED UNSPECIFIED UNSPECIFIED Ramelet, A. A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Tessari, L. UNSPECIFIED UNSPECIFIED UNSPECIFIED Pannier, F. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-434984
DOI:	10.1177/0268355513483280
Journal or Publication Title:	Phlebology
Volume:	29
Number:	6
Page Range:	S. 338 - 355
Date:	2014
Publisher:	SAGE PUBLICATIONS INC
Place of Publication:	THOUSAND OAKS
ISSN:	1758-1125
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language GUIDED FOAM SCLEROTHERAPY; GREAT SAPHENOUS-VEIN; RANDOMIZED CONTROLLED-TRIAL; INCOMPETENT PERFORATOR VEINS; 3-PERCENT POLIDOCANOL FOAM; SODIUM TETRADECYL SULFATE; RECURRENT VARICOSE-VEINS; CLINICAL-TRIAL; DOUBLE-BLIND; NEUROLOGICAL COMPLICATIONS Multiple languages Surgery; Peripheral Vascular Disease Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/43498